RIPK1 inhibition limits expansion of pathogenic double-negative T cells in preclinical autoimmune lymphoproliferative syndrome models

Author profile image Aggregator
0 comments
Autoimmune lymphoproliferative syndrome (ALPS) is an immune disorder characterized by defective lymphocyte apoptosis, leading to lymphoproliferation, autoimmunity, and increased lymphoma risk. Although disease severity correlates with the expansion of double-negative T (DNT) cells, the mechanisms governing their aberrant generation and pathogenicity remain elusive. Through single-cell transcriptomics of peripheral blood from pediatric patients with ALPS, including patients harboring new FAS cell...

Source: PubMed - functional neurological disorder Published 18 Nov 2026 Imported 19 Nov 2026 Relevancy: Not reviewed

Read the article